About Anuh Pharma Limited
Data last updated: 28 July 2026
Anuh Pharma Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 19 February 1960, the company has been in operation for over 66 years.
Registered with ROC Mumbai under CIN L24230MH1960PLC011586. Listed on BSE: 506260.
Capital: an authorised share capital of ₹51 Cr and a paid-up capital of ₹50.11 Cr. It is led by directors including Arun Lalchand Todarwal and Bharat Nemchand Shah.
Last AGM: 22 August 2025. Financial statements filed for year ended 31 March 2025. Office: A 3 Shiv Sagar Estatedr Annie Besant Road, Mumbai, Maharashtra, India – 400018.
As per NSE-filed standalone financials for FY 2026, the company reported a revenue of ₹771.66 Cr, a growth of 16.65% compared to the previous year. The net worth stands at ₹352.22 Cr (up 8.04% YoY). Total assets are valued at ₹557.37 Cr (up 10.02% YoY).
The company has a workforce of approximately 212 employees as per the latest available data.
The company is associated with 2 brands - Anuh Pharma, Sk Age Exports. As per MCA filings, the company has open charges of ₹95 Cr and satisfied charges of ₹112.11 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website anuhpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressA 3 Shiv Sagar Estatedr Annie Besant Road, Mumbai, Maharashtra, India – 400018
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Anuh Pharma Limited
Anuh Pharma Limited has one previous CIN (Corporate Identification Number): U24230MH1960PLC011586. The current CIN is L24230MH1960PLC011586, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24230MH1960PLC011586 | Current |
| U24230MH1960PLC011586 | Previous |
Associated Brands with Anuh Pharma Limited
Anuh Pharma Limited operates two associated brands: Anuh Pharma and SK Age Exports. These brands represent Anuh Pharma Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs, bulk drugs, and formulations are manufactured and traded. | anuhpharma.com | |
| International goods exports are managed from Mumbai, India. | skageexports.com |
Competitors & Alternatives of Anuh Pharma Limited
Brands and companies operating in the same space as Anuh Pharma Limited include Concord Biotech, Almac Group, Indoco Remedies and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Anuh Pharma Limited
Anuh Pharma Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Anuh Pharma Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Anuh Pharma Limited
Anuh Pharma Limited is audited by JAYANTILAL THAKKAR & CO. (ICAI peer reviewed, certificate valid till 2027-03-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| JAYANTILAL THAKKAR & CO. (ICAI peer reviewed, certificate valid till 2027-03-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Anuh Pharma Limited
Anuh Pharma Limited is currently managed by 12 directors, with 13 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Arun Lalchand Todarwal
Also directs:
Arun Todarwal & Associates Llp, Arun Todarwal & Co Llp, Laxmi Organic Industries Limited and 5 more
|
Director | 24 Oct 2008 | 17 Years 9 Months | Current |
| Bharat Nemchand Shah | Director | 29 Oct 1980 | 45 Years 9 Months | Current |
|
Ritesh Bipin Shah
Also directs:
Anuh Pharma Limited, S Kant Healthcare Limited
|
Managing Director | 09 Aug 2016 | 10 Years 0 Months | Current |
|
Samir Jayantilal Shah
Also directs:
Anuh Pharma Limited, Eskay Iodine Private Limited, Chaitanya Life Science Private Limited and 5 more
|
Director | 09 Aug 2016 | 10 Years 0 Months | Current |
|
Ketan Lalit Shah
Also directs:
Anuh Pharma Limited, Eskay Iodine Private Limited, Chaitanya Life Science Private Limited and 3 more
|
Director | 09 Aug 2016 | 10 Years 0 Months | Current |
|
Bipin Nemchand Shah
Also directs:
Anuh Pharma Limited, Eskay Iodine Private Limited, Chaitanya Life Science Private Limited and 1 more
|
Director | 01 Apr 2009 | 17 Years 4 Months | Current |
Financials of Anuh Pharma Limited FY 2026 filings available
Anuh Pharma Limited reported revenue of ₹771.66 Cr (up 16.65% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹771.66 Cr | ₹661.51 Cr |
| Other Income | ₹4.36 Cr | ₹9.46 Cr |
| Total Income | ₹776.01 Cr | ₹670.97 Cr |
| Cost of Materials Consumed | ₹510.44 Cr | ₹463.28 Cr |
| Purchases of Stock-in-Trade | ₹79.2 Cr | ₹38.55 Cr |
| Changes in Inventories | ₹10.02 Cr | -₹2.45 Cr |
| Employee Benefit Expense | ₹26.3 Cr | ₹23.04 Cr |
| Finance Costs | ₹47.23 Lakh | ₹61.93 Lakh |
| Depreciation & Amortisation | ₹11.38 Cr | ₹8.74 Cr |
| Other Expenses | ₹83.97 Cr | ₹78.2 Cr |
| Total Expenses | ₹721.79 Cr | ₹609.96 Cr |
| Profit Before Exceptional Items & Tax | ₹54.22 Cr | ₹61.01 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹54.22 Cr | ₹61.01 Cr |
| Total Tax Expense | ₹13.18 Cr | ₹13.65 Cr |
| Net Profit | ₹41.05 Cr | ₹47.35 Cr |
| Other Comprehensive Income | ₹18.51 Lakh | -₹1.7 Lakh |
| Total Comprehensive Income | ₹41.23 Cr | ₹47.33 Cr |
| EBITDA (computed) | ₹66.08 Cr | ₹70.36 Cr |
| Basic EPS | ₹4.10 | ₹9.45 |
| Diluted EPS | ₹4.10 | ₹9.45 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹557.37 Cr | ₹506.63 Cr |
| Non-current Assets | ₹106.05 Cr | ₹130.46 Cr |
| Current Assets | ₹451.32 Cr | ₹376.17 Cr |
| Property, Plant & Equipment | ₹47.99 Cr | ₹49.58 Cr |
| Inventories | ₹147.76 Cr | ₹74.48 Cr |
| Trade Receivables | ₹238.63 Cr | ₹215.87 Cr |
| Cash & Equivalents | ₹8.06 Cr | ₹19.56 Cr |
| Equity (Net Worth) | ₹352.22 Cr | ₹326.02 Cr |
| Equity Share Capital | ₹50.11 Cr | ₹25.06 Cr |
| Borrowings (Non-current) | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹10.5 Cr |
| Total Debt (computed) | ₹0 | ₹10.5 Cr |
| Current Liabilities | ₹203 Cr | ₹178.51 Cr |
| Total Liabilities | ₹205.15 Cr | ₹180.6 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | -₹3.01 Cr | ₹37.12 Cr |
| Investing Cash Flow | ₹17.84 Cr | -₹19.91 Cr |
| Financing Cash Flow | -₹26.33 Cr | -₹4.86 Cr |
| Capital Expenditure | ₹7.87 Cr | ₹19.96 Cr |
| Free Cash Flow (computed) | -₹10.88 Cr | ₹17.16 Cr |
| Dividends Paid | ₹14.97 Cr | ₹12.52 Cr |
| Net Change in Cash | -₹11.5 Cr | ₹12.36 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 |
|---|---|---|---|---|---|---|
| Revenue from Operations | ₹202.12 Cr | ₹197.18 Cr | ₹185.88 Cr | ₹186.48 Cr | ₹198.14 Cr | ₹159.51 Cr |
| Other Income | -₹1.25 Cr | ₹4.11 Cr | ₹97.85 Lakh | ₹3.39 Cr | ₹1.4 Cr | ₹93.76 Lakh |
| Total Income | ₹200.86 Cr | ₹201.29 Cr | ₹186.86 Cr | ₹189.87 Cr | ₹199.54 Cr | ₹160.45 Cr |
| Cost of Materials Consumed | ₹140.71 Cr | ₹114.31 Cr | ₹131.51 Cr | ₹123.91 Cr | ₹137.92 Cr | ₹118.65 Cr |
| Purchases of Stock-in-Trade | ₹2.83 Cr | ₹31.48 Cr | ₹18.39 Cr | ₹26.5 Cr | ₹10.93 Cr | ₹14.55 Cr |
| Changes in Inventories | ₹7.68 Cr | ₹5.48 Cr | -₹5.37 Cr | ₹2.22 Cr | -₹38.3 Lakh | -₹12.73 Cr |
| Employee Benefit Expense | ₹6.35 Cr | ₹6.91 Cr | ₹6.75 Cr | ₹6.3 Cr | ₹6.85 Cr | ₹5.54 Cr |
| Finance Costs | ₹10.58 Lakh | ₹7.96 Lakh | ₹7.56 Lakh | ₹21.13 Lakh | ₹3.35 Lakh | ₹28.03 Lakh |
| Depreciation & Amortisation | ₹3 Cr | ₹3 Cr | ₹2.86 Cr | ₹2.52 Cr | ₹2.76 Cr | ₹2.18 Cr |
| Other Expenses | ₹24.66 Cr | ₹22.19 Cr | ₹22.72 Cr | ₹17.27 Cr | ₹24.16 Cr | ₹18.71 Cr |
| Total Expenses | ₹185.34 Cr | ₹183.46 Cr | ₹176.94 Cr | ₹178.91 Cr | ₹182.26 Cr | ₹147.19 Cr |
| Profit Before Exceptional Items & Tax | ₹15.52 Cr | ₹17.83 Cr | ₹9.92 Cr | ₹10.95 Cr | ₹17.28 Cr | ₹13.27 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹15.52 Cr | ₹17.83 Cr | ₹9.92 Cr | ₹10.95 Cr | ₹17.28 Cr | ₹13.27 Cr |
| Total Tax Expense | ₹3.84 Cr | ₹4.38 Cr | ₹2.31 Cr | ₹2.65 Cr | ₹4.82 Cr | ₹2.92 Cr |
| Net Profit | ₹11.68 Cr | ₹13.45 Cr | ₹7.61 Cr | ₹8.3 Cr | ₹12.46 Cr | ₹10.34 Cr |
| Other Comprehensive Income | -₹29.34 Lakh | ₹45.55 Lakh | ₹8.37 Lakh | -₹6.07 Lakh | ₹10.27 Lakh | ₹77,000 |
| Total Comprehensive Income | ₹11.39 Cr | ₹13.91 Cr | ₹7.7 Cr | ₹8.24 Cr | ₹12.56 Cr | ₹10.35 Cr |
| EBITDA (computed) | ₹18.63 Cr | ₹20.91 Cr | ₹12.86 Cr | ₹13.68 Cr | ₹20.07 Cr | ₹15.73 Cr |
| Basic EPS | ₹1.17 | ₹1.34 | ₹0.76 | ₹1.66 | ₹2.49 | ₹2.06 |
| Diluted EPS | ₹1.17 | ₹1.34 | ₹0.76 | ₹1.66 | ₹2.49 | ₹2.06 |
Shareholding Pattern of Anuh Pharma Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 71.80%, foreign institutional investors hold 0.05%, domestic institutional investors hold 0.00%, retail and other public shareholders hold 28.16% of Anuh Pharma Limited. The company had 27,425 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jul 2025 | Jun 2025 | Mar 2025 | |
|---|---|---|---|---|---|---|
| Promoters | 71.80% | 71.82% | 71.82% | 69.92% | 69.92% | 69.92% |
| Public | 28.20% | 28.18% | 28.18% | 30.08% | 30.08% | 30.08% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 71.80% | 69.92% |
| Public | 28.20% | 30.08% |
| Promoter change (YoY, %pts) | +1.88 | - |
Board & Governance of Anuh Pharma Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Anuh Pharma Limited has 12 directors - 4 independent and 2 executive. The board is chaired by Arun Lalchand Todarwal.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Arun Lalchand Todarwal | Non-Executive - Non Independent Director · Chairperson | 2014-04-01 | 4 |
| Bipin Nemchand Shah | Non-Executive - Non Independent Director | 2009-04-01 | 1 |
| Bharat Nemchand Shah | Non-Executive - Non Independent Director | 1980-10-29 | 1 |
| Samir Jayantilal Shah | Non-Executive - Non Independent Director | 2016-08-09 | 1 |
| Ketan Lalitkumar Shah | Non-Executive - Non Independent Director | 2016-08-09 | 1 |
| Ritesh Bipin Shah | Executive Director · MD | 2016-08-09 | 1 |
| Vivek Bipin Shah | Executive Director · MD | 2016-08-09 | 1 |
| Mita Chittaranjan Dixit | Non-Executive - Independent Director | 2019-02-08 | 3 |
| Harmanbhai Tulshibhai Patel | Non-Executive - Independent Director | 2019-05-22 | 1 |
| Gaurav Satish Shah | Non-Executive - Non Independent Director | 2023-07-01 | 1 |
| Siddharth Jasvantlal Shah | Non-Executive - Independent Director | 2024-04-01 | 1 |
| Pradeep Hari Thakur | Non-Executive - Independent Director | 2024-04-01 | 3 |
| Committee | Members |
|---|---|
| Audit Committee | Harmanbhai Tulshibhai Patel (Chairperson), Bipin Nemchand Shah, Arun Lalchand Todarwal, Siddharth Jasvantlal Shah, Pradeep Hari Thakur, Mita Chittaranjan Dixit |
| Nomination and remuneration committee | Mita Chittaranjan Dixit (Chairperson), Arun Lalchand Todarwal, Harmanbhai Tulshibhai Patel, Siddharth Jasvantlal Shah |
| Stakeholders Relationship Committee | Bharat Nemchand Shah (Chairperson), Bipin Nemchand Shah, Ketan Lalitkumar Shah, Siddharth Jasvantlal Shah |
| Corporate Social Responsibility Committee | Siddharth Jasvantlal Shah (Chairperson), Bipin Nemchand Shah, Arun Lalchand Todarwal |
Charges & Borrowings of Anuh Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Feb 2017 | Hdfc Bank Limited | ₹95 Cr | Open |
| 06 Jan 2007 | Bank of India | ₹65 Cr | Satisfied |
| 20 Mar 1999 | Bank of India | ₹25 Lakh | Satisfied |
| 23 Apr 1997 | Bank of India | ₹20 Lakh | Satisfied |
| 19 Jul 1995 | Bank of India | ₹45 Cr | Satisfied |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Anuh Pharma Limited
Anuh Pharma Limited has a workforce of 212 employees as of Apr 08, 2024.
Employee and EPFO history for Anuh Pharma Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Anuh Pharma Limited
GST registrations and filing compliance for Anuh Pharma Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Anuh Pharma Limited
Credit ratings, litigation, and regulatory alerts for Anuh Pharma Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Anuh Pharma Limited
MSME payment history for Anuh Pharma Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Anuh Pharma Limited
Corporate group structure for Anuh Pharma Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Anuh Pharma Limited
MCA filings and documents for Anuh Pharma Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Anuh Pharma Limited
Recent News on Anuh Pharma Limited
Frequently Asked Questions about Anuh Pharma Limited
Anuh Pharma Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 19 February 1960 (66+ years old) and is registered under CIN L24230MH1960PLC011586. Listed on BSE: 506260. The company has 212 employees.
Anuh Pharma Limited reported revenue of ₹771.66 Cr for FY 2026 (up 16.65% YoY) based on standalone NSE filings.
The current directors of Anuh Pharma Limited are:
- Arun Lalchand Todarwal - Director
- Bharat Nemchand Shah - Director
- Ritesh Bipin Shah - Managing Director
- Samir Jayantilal Shah - Director
- Ketan Lalit Shah - Director
- Bipin Nemchand Shah - Director
- Vivek Bipin Shah - Managing Director
- Mita Dixit - Director
- Harmanbhai Tulshibhai Patel - Director
- Pradeep Hari Thakur - Director
- Siddharth Shah Jasvantlal - Director
- Gaurav Satish Shah - Director
The primary industry of Anuh Pharma Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Yes. Anuh Pharma Limited is listed on BSE with code 506260.
Anuh Pharma Limited can be reached at the registered office: A 3 Shiv Sagar Estatedr Annie Besant Road, Mumbai, Maharashtra, India – 400018, or through the website anuhpharma.com.